Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dexamethasone, quantity: 0.5 mg/ml; framycetin sulfate, quantity: 5 mg/ml; gramicidin, quantity: 0.05 mg/ml - ear drops - excipient ingredients: phenethyl alcohol; polysorbate 80; citric acid monohydrate; sodium citrate dihydrate; lithium chloride; purified water; industrial methylated spirit; hydrochloric acid; sodium hydroxide - indications as at 5 october 2000: inflammatory and allergic conditions of the ear, e.g. otitis externa. eczema of the auditory meatus is often present and causes inflammation, exudation and pruritus, which are all rapidly relieved by dexamethasone. infection,often secondary to scratching, is generally due to staphylococci, e. coli, pseudomonas and proteus spp. which respond rapidly to framycetin.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dexamethasone, quantity: 0.5 mg/ml; framycetin sulfate, quantity: 5 mg/ml; gramicidin, quantity: 0.05 mg/ml - ear drops - excipient ingredients: phenethyl alcohol; polysorbate 80; citric acid monohydrate; sodium citrate dihydrate; lithium chloride; purified water; industrial methylated spirit; sodium hydroxide; hydrochloric acid - indications as at 22 march 1993: inflammatory and allergic conditions of the ear, e.g. otitis externa. eczema of the auditory meatus is often present and causes inflammation, exudation and pruritus, which are all rapidly relieved by dexamethasone. infection,often secondary to scratching, is generally due to staphylococci, e. coli, pseudomonas and proteus spp. which respond rapidly to framycetin.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - gramicidin 0.25 mg/g; neomycin sulfate 2.5 mg/g; nystatin 100000 u/g ((+ 5% excess, approx 35mg/g)); triamcinolone acetonide 1 mg/g ((3% manufacturing overage)) - ear drops - active: gramicidin 0.25 mg/g neomycin sulfate 2.5 mg/g nystatin 100000 u/g ((+ 5% excess, approx 35mg/g)) triamcinolone acetonide 1 mg/g ((3% manufacturing overage)) excipient: liquid paraffin polyethylene - the topical treatment of superficial bacterial infections, cutaneous candidosis and dermatological conditions known to respond to topical steroid therapy when threatened or complicated by bacterial or candidal superinfections, especially otitis externa.

United States - English - NLM (National Library of Medicine)

bausch & lomb incorporated - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), gramicidin (unii: 5ie62321p4) (gramicidin - unii:5ie62321p4) - neomycin 1.75 mg in 1 ml - neomycin and polymyxin b sulfates and gramicidin ophthalmic solution is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. this product is contraindicated in those persons who have shown hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), gramicidin (unii: 5ie62321p4) (gramicidin - unii:5ie62321p4) - neomycin 1.75 mg in 1 ml - neomycin and polymyxin b sulfates and gramicidin ophthalmic solution is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. this product is contraindicated in those persons who have shown hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), gramicidin (unii: 5ie62321p4) (gramicidin - unii:5ie62321p4) - neomycin sulfate 1.75 mg in 1 ml - neomycin and polymyxin b sulfates and gramicidin ophthalmic solution is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. this product is contraindicated in those persons who have shown hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), gramicidin (unii: 5ie62321p4) (gramicidin - unii:5ie62321p4) - neomycin sulfate 1.75 mg in 1 ml - neomycin and polymyxin b sulfates and gramicidin ophthalmic solution is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. this product is contraindicated in those persons who have shown hypersensitivity to any of its components.

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - ointment - triamcinolone acetonide 1 mg/g; neomycin as sulfate 2.5 mg/g; gramicidin 0.25 mg/g; nystatin 100000 iu/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - cream - nystatin 100000 iu/g; gramicidin 0.25 mg/g; neomycin as sulfate 2.5 mg/g; triamcinolone acetonide 1 mg/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - gramicidin 0.25 mg/g (+10% overage); neomycin sulfate 2.5 mg/g (+25% overage); nystatin 100000 u/g (+ 30% overage); triamcinolone acetonide 1 mg/g (+4% overage) - topical cream - active: gramicidin 0.25 mg/g (+10% overage) neomycin sulfate 2.5 mg/g (+25% overage) nystatin 100000 u/g (+ 30% overage) triamcinolone acetonide 1 mg/g (+4% overage) excipient: cetomacrogol citric acid monohydrate dibasic sodium phosphate monohydrate ethanol liquid paraffin methyl hydroxybenzoate perfume 5254 propyl hydroxybenzoate propylene glycol purified water white soft paraffin - the topical treatment of superficial bacterial infections, cutaneous candidosis and dermatological conditions known to respond to topical steroid therapy when threatened or complicated by bacterial or candidal superinfections. these include; atopic eczema, contact eczema, follicular eczema, infantile eczema, anogenital pruritis (anal and vulval pruritis), nummular eczema, post-traumatic infective eczema, seborrhocic or flexural eczema, neurodermatitis, psoriasis.